Diagnostic methods
Article 6
1. The competent authority shall ensure that the collection of samples, the techniques, validation and interpretation of the diagnostic methods for the purposes of surveillance shall comply: (a) with the specific legislation adopted in accordance with Regulation (EU) 2016/429 and the relevant details and guidance made available on the websites of the European Union Reference Laboratories (EURL) and of the Commission; (b) when not covered by the legislation, details and guidance referred to in point (a), with the collection of samples, the techniques, validation and interpretation of the diagnostic methods laid down in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health (OIE) (‘the Terrestrial Manual’ ( 21 ) as amended or the Manual of Diagnostic Tests for Aquatic Animals of the OIE (‘the Aquatic Manual’ ( 22 ) as amended; (c) when not covered by points (a) and (b) of this paragraph, with the methods laid down in point (b) of Article 34(2) and Article 34(3) of Regulation (EU) 2017/625. 2. The diagnostic methods for granting and maintaining disease-free status are laid down in: (a) Section 1 of Annex III for infection with Brucella abortus, B. melitensis and B.suis ; (b) Section 2 of Annex III for infection with Mycobacterium tuberculosis complex ( Mycobacterium bovis, M.caprae and M. tuberculosis ) (MTBC); (c) Section 3 of Annex III for enzootic bovine leukosis (EBL); (d) Section 4 of Annex III for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV); (e) Section 5 of Annex III for infection with Aujeszky’s disease virus (ADV); (f) Section 6 of Annex III for bovine viral diarrhoea (BVD); (g) point 2 of Section 5 of Chapter 1 of Part II of Annex VI for viral haemorrhagic septicaemia (VHS); (h) point 2 of Section 5 of Chapter 1 of Part II of Annex VI for infectious haematopoietic necrosis (IHN); (i) point 2 of Section 5 of Chapter 2 of Part II of Annex VI for infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV); (j) point 2 of Section 5 of Chapter 3 of Part II of Annex VI for infection with Marteilia refringens ; (k) point 2 of Section 5 of Chapter 4 of Part II of Annex VI for infection with Bonamia exitiosa ; (l) point 2 of Section 5 of Chapter 5 of Part II of Annex VI for infection with Bonamia ostreae ; (m) point 2 of Section 5 of Chapter 6 of Part II of Annex VI for infection with white spot syndrome virus (WSSV).